Live Breaking News & Updates on Analyst Recommendations For Jazz Pharmaceuticals

Stay updated with breaking news from Analyst recommendations for jazz pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jazz Pharmaceuticals' (JAZZ) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

Jazz Pharmaceuticals' (JAZZ) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Neenam Patil , Jazz Pharmaceuticals , Analyst Recommendations For Jazz Pharmaceuticals , Cantor Fitzgerald , Advisor Group , Vanguard Group Inc , Royal Bank , Securities Exchange Commission , Needham Company , Us Bancorp , Insider Activity At Jazz Pharmaceuticals , Aviva Plc , Jazz Pharmaceuticals Price Performance , News Ratings For Jazz Pharmaceuticals Daily , Free Report , Jazz Pharmaceutical , Get Free Report , Exchange Commission , Asset Management Gmbh , Vanguard Group , Jazz Pharmaceuticals Daily ,

Jazz Pharmaceuticals' (JAZZ) Overweight Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a research note issued to investors on Monday morning, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Jazz Pharmaceuticals’ FY2023 earnings at $14.27 EPS and FY2024 earnings at $15.79 EPS. Other analysts have also issued research reports about the […] ....

United States , Neenam Patil , Jazz Pharmaceuticals , Needham Company , Royal Bank , Advisors Inc , Jazz Pharmaceuticals Stock Performance , Institutional Investors Weigh In On Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Securities Exchange Commission , Huntington National Bank , Analyst Recommendations For Jazz Pharmaceuticals , Cantor Fitzgerald , S Capital Wealth Advisors , Free Report , Jazz Pharmaceutical , Get Free Report , Exchange Commission , Wealth Management , National Bank , Wealth Advisors , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Reiterated Rating ,

Jazz Pharmaceuticals' (JAZZ) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

Jazz Pharmaceuticals' (JAZZ) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United States , Neenam Patil , Analyst Recommendations For Jazz Pharmaceuticals , Needham Company , News Ratings For Jazz Pharmaceuticals Daily , Hedge Funds Weigh In On Jazz Pharmaceuticals , Envestnet Asset Management Inc , Insider Transactions At Jazz Pharmaceuticals , Royal Bank , Pacer Advisors Inc , Cantor Fitzgerald , Jazz Pharmaceuticals Trading , Securities Exchange Commission , Jazz Pharmaceuticals Company Profile , Jazz Pharmaceuticals , Baupost Group , Free Report , Get Free Report , Exchange Commission , Asset Management , Partners Management , Jazz Pharmaceuticals Daily ,

Analysts Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Target Price at $200.75

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) has been given a consensus recommendation of “Moderate Buy” by the eight research firms that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month target […] ....

United States , Neenam Patil , News Ratings For Jazz Pharmaceuticals Daily , Institutional Investors Weigh In On Jazz Pharmaceuticals , S Capital Wealth Advisors , Royal Bank , Jazz Pharmaceuticals , Securities Exchange Commission , Huntington National Bank , Needham Company , Jazz Pharmaceuticals Company Profile , Insider Activity At Jazz Pharmaceuticals , Jazz Pharmaceuticals Stock Performance , Analyst Recommendations For Jazz Pharmaceuticals , Advisors Inc , Free Report , Marketbeat Ratings , Exchange Commission , Wealth Management , National Bank , Wealth Advisors , Jazz Pharmaceuticals Daily ,

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives Average Rating of "Moderate Buy" from Analysts

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) has received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price target among brokerages […] ....

United States , Neenam Patil , Advisors Inc , First Republic Investment Management Inc , Analyst Recommendations For Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals Company Profile , Royal Bank , Jazz Pharmaceuticals , Insider Activity At Jazz Pharmaceuticals , Jazz Pharmaceuticals Stock Performance , Needham Company , Sequoia Financial Advisors , Free Report , Avenue Securities , Financial Advisors , First Republic Investment Management , Republic Investment Management , Jazz Pharmaceuticals Daily ,